Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The American Association for Cancer Research initiative will foster collaboration and advance lifesaving scientific discoveries
The Summit’s continuing focus has been on the implementation of biomedical tools in our prevention and treatment efforts.
Report includes call to action outlining steps Congress must take to maintain momentum.
Already, more than 100 million Americans don’t have regular access to primary care, a number that has nearly doubled since 2014.
A new analysis confirms the American Institute for Cancer Research’s tips for lowering the risk of breast, colorectal and lung cancers.
There are now three FDA-approved PrEP medications in the United States—two are pills, and one is a shot.
These plant-based meals are quick, delicious and healthy any time of the year.
The USPSTF’s latest recommendation could make long-acting PrEP (Apretude) more accessible—if a looming court case doesn’t interfere.
Dr. Marrazzo is a renowned HIV and STI expert at the University of Alabama Birmingham.
The American Institute for Cancer Research offers cancer prevention recommendations as a path to diet quality.
The proposal improves on current Medicare coverage, which allows cost-sharing fees and mostly excludes long-acting PrEP.
Part 3 in a series from the University of Colorado that unpacks the goals of the National Cancer Institute’s National Cancer Plan.
Part 2 in a series from the University of Colorado that unpacks the goals of the National Cancer Institute’s National Cancer Plan.
The $3.6 billion antitrust court case cleared Gilead Sciences and Teva of delaying the release of generic Truvada and other HIV meds.
Ending the mandate to cover preventive care such as PrEP “will cause incalculable harm to our efforts to end the HIV epidemic.”
Daily dosing or long-acting injectables may be better options for those who have spontaneous sex.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.